ClinicaliQ Trial Snapshot
- A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors — Active Not Recruiting • Phase III • Dermatology • NCT05135559.
- Concizumab daily injections tested in haemophilia A/B patients to prevent bleeds over 2-4 years.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study will test how well a new medicine called concizumab works for participants who have haemophilia A or B with or without inhibitors. The purpose is to show that concizumab can prevent bleeds and is safe to use. Participants will have to inject the study medicine every day under the skin with a pen-injector. The study will last for at least 2 years and up to about 4 years. The length of time the participant will be in the study depends on if the study medicine will be available…